An Eight-week, Randomized, Double-blind Multicenter Study to Compare the Efficacy and Safety of Amosartan Tab 5/100mg Versus Cozaar Plus Pro Tab in Patients With Essential Hypertension Uncontrolled With Losartan 100mg Monotherapy

Trial Profile

An Eight-week, Randomized, Double-blind Multicenter Study to Compare the Efficacy and Safety of Amosartan Tab 5/100mg Versus Cozaar Plus Pro Tab in Patients With Essential Hypertension Uncontrolled With Losartan 100mg Monotherapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Apr 2013

At a glance

  • Drugs Amlodipine/losartan (Primary) ; Hydrochlorothiazide; Losartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Hanmi Pharmaceutical
  • Most Recent Events

    • 16 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top